Hydrafacial Results Presentation Deck

2022 OUTLOOK: CONFIDENCE IN OUR ABILITY TO EXECUTE Strong track record of net sales outperformance ($mm) Consensus Estimate Actual $44.1$47.5 1Q21 +7.8% $166.6 $66.5 2019 Actual $49.2 Net sales outlook ($mm) 2Q21 +35.2% $119.1 2020 Actual $68.1 $58.0 3Q21 +17.5% $260.1 2021 Actual $77.9 $71.1 4Q21 +9.5% $320- $330 2022 Outlook (Feb) $68.1 $75.4 Source: FactSet complied consensus Note: Percentages may not recalculate due to rounding ¹ Non-GAAP measure; please refer to the appendix for a reconciliation to the appropriate GAAP measure 1Q22 +10.7% $330- $340 2022 Outlook (May) $103.5 $83.9 2Q22 +23.4% $340- $350 2022 Outlook (Aug) 20 Adjusted EBITDA outlook ($mm)¹ $32.7 2021 Actual $50.0 2022 Outlook BEAUTYHEALTH™

View entire presentation